Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 29;13:6473. doi: 10.1038/s41467-022-34171-2

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 4 — a Correlation between the number of intact proviruses detected per million of CD4⁺ T cells detected after 365 days of ART (immediately preceding ATI) and days to first detectable viremia during ATI (n = 17). Individual dots are color-coded according to the groups. R and P-values were calculated using two-sided Spearman rank-order correlation. b Frequency of Gag-specific CD8⁺ T cell and percentage of individuals showing a decreased or increased frequency of Gag-specific CD8⁺ T cell responses (%) from Day 0 to Day 365 is shown for individuals that experienced a viral rebound (left, n = 13) in comparison to individuals that maintained a virological control during the ATI period (right, n = 7). P-value was calculated using two-sided Fisher’s exact test. c The proportion of individuals with high INF-γ (>750 pg/mL) versus low INF-γ (<750 pg/mL) who maintained viral control during 12 weeks of ATI (n = 20). P-value was calculated using log-rank test. Source data are provided as a Source Data file.